tiprankstipranks
Advertisement
Advertisement

MAIA Stock Latest News

MAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion
The FlyMAIA Biotechnology reports efficacy data from Phase 2 THIO-101 Part C expansion
25d ago
MAIA
MAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial
PremiumThe Fly
MAIA Biotechnology opens third clinical site in U.S. for Phase 2 THIO-101 trial
2M ago
MAIA
MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial
PremiumThe Fly
MAIA Biotechnology reports 29 patients dosed in Phase 3 THIO-104 trial
2M ago
MAIA
MAIA Biotechnology receives FDA clearance for amendment to IND application
PremiumThe Fly
MAIA Biotechnology receives FDA clearance for amendment to IND application
2M ago
MAIA
MAIA Biotechnology announces open market purchases by CEO, director
PremiumThe Fly
MAIA Biotechnology announces open market purchases by CEO, director
2M ago
MAIA
MAIA Biotechnology Shareholders Back Board and Auditor Appointments
PremiumCompany AnnouncementsMAIA Biotechnology Shareholders Back Board and Auditor Appointments
2M ago
8K
MAIA
MAIA Biotechnology Ends ATM Stock Offering Agreement
Premium
Company Announcements
MAIA Biotechnology Ends ATM Stock Offering Agreement
3M ago
8K
MAIA
MAIA Expands THIO-101 Lung Cancer Trial in U.S.
Premium
Company Announcements
MAIA Expands THIO-101 Lung Cancer Trial in U.S.
4M ago
8K
MAIA
MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial
PremiumCompany Announcements
MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial
4M ago
8K
MAIA
MAIA Biotechnology secures funding for clinical trial of ateganosine
PremiumThe Fly
MAIA Biotechnology secures funding for clinical trial of ateganosine
4M ago
MAIA
MAIA Biotechnology Awards Executive Bonuses After Successful Financing
PremiumCompany Announcements
MAIA Biotechnology Awards Executive Bonuses After Successful Financing
4M ago
8K
MAIA
MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes
PremiumCompany Announcements
MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes
4M ago
8K
MAIA
MAIA Showcases THIO-101 NSCLC Data at ELCC 2026
PremiumCompany AnnouncementsMAIA Showcases THIO-101 NSCLC Data at ELCC 2026
4M ago
8K
MAIA
MAIA Biotechnology Completes $30 Million Public Stock Offering
Premium
Company Announcements
MAIA Biotechnology Completes $30 Million Public Stock Offering
5M ago
8K
MAIA
MAIA Biotechnology 20M share Spot Secondary priced at $1.50
Premium
The Fly
MAIA Biotechnology 20M share Spot Secondary priced at $1.50
5M ago
MAIA
MAIA Biotechnology announces common stock offering, no amount given
PremiumThe Fly
MAIA Biotechnology announces common stock offering, no amount given
5M ago
MAIA
MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program
PremiumCompany Announcements
MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program
5M ago
8K
MAIA
MAIA Biotechnology published a 2026 Letter to Shareholders
PremiumThe Fly
MAIA Biotechnology published a 2026 Letter to Shareholders
5M ago
MAIA
MAIA Biotechnology outlines 2026 goals for ateganosine program
PremiumCompany Announcements
MAIA Biotechnology outlines 2026 goals for ateganosine program
6M ago
8K
MAIA
MAIA Biotechnology highlights milestones, catalysts for FY26
PremiumThe FlyMAIA Biotechnology highlights milestones, catalysts for FY26
6M ago
MAIA
MAIA Biotechnology Highlights Strategy in New Investor Presentation
Premium
Company Announcements
MAIA Biotechnology Highlights Strategy in New Investor Presentation
7M ago
8K
MAIA
MAIA Biotechnology directors participate in private placement financings
Premium
The Fly
MAIA Biotechnology directors participate in private placement financings
7M ago
MAIA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >